RJT
CVS icon

Raymond James Trust’s CVS Health CVS Stock Holding History

Raymond James Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$17.6M Sell
279,293
-9,310
-3% -$543K 0.38% 59
2024
Q2 		$17M Buy
288,603
+2,538
+0.9% +$159K 0.4% 58
2024
Q1 		$22.8M Buy
286,065
+200
+0.1% +$15.3K 0.55% 41
2023
Q4 		$22.6M Sell
285,865
-46,749
-14% -$3.33M 0.6% 36
2023
Q3 		$23.2M Buy
332,614
+3,159
+1% +$224K 0.69% 31
2023
Q2 		$22.8M Sell
329,455
-902
-0.3% -$64.2K 0.66% 34
2023
Q1 		$24.5M Sell
330,357
-1,896
-0.6% -$159K 0.78% 24
2022
Q4 		$31M Sell
332,253
-14,519
-4% -$1.4M 1.04% 14
2022
Q3 		$33.1M Buy
346,772
+3,427
+1% +$339K 1.23% 9
2022
Q2 		$31.8M Sell
343,345
-2,675
-0.8% -$261K 1.14% 11
2022
Q1 		$35M Sell
346,020
-7,089
-2% -$745K 1.08% 12
2021
Q4 		$36.4M Buy
353,109
+135,642
+62% +$12.5M 1.08% 12
2021
Q3 		$18.5M Sell
217,467
-8,247
-4% -$691K 0.62% 39
2021
Q2 		$18.8M Sell
225,714
-5,567
-2% -$456K 0.63% 39
2021
Q1 		$17.4M Buy
231,281
+957
+0.4% +$69.7K 0.61% 40
2020
Q4 		$15.7M Buy
230,324
+5,013
+2% +$326K 0.6% 43
2020
Q3 		$13.2M Buy
225,311
+7,302
+3% +$454K 0.57% 44
2020
Q2 		$14.2M Buy
218,009
+15,209
+7% +$958K 0.69% 38
2020
Q1 		$12M Buy
202,800
+18,469
+10% +$1.23M 0.71% 33
2019
Q4 		$13.7M Buy
184,331
+9,324
+5% +$655K 0.65% 38
2019
Q3 		$11M Buy
175,007
+7,121
+4% +$422K 0.57% 42
2019
Q2 		$9.15M Buy
167,886
+6,924
+4% +$373K 0.5% 51
2019
Q1 		$8.68M Buy
160,962
+21,193
+15% +$1.31M 0.5% 52
2018
Q4 		$9.16M Buy
139,769
+8,344
+6% +$623K 0.59% 42
2018
Q3 		$10.3M Buy
131,425
+2,321
+2% +$166K 0.58% 41
2018
Q2 		$8.31M Sell
129,104
-1,390
-1% -$91.6K 0.51% 50
2018
Q1 		$8.12M Buy
130,494
+1,044
+0.8% +$74.9K 0.56% 48
2017
Q4 		$9.38M Buy
129,450
+1,843
+1% +$134K 0.63% 41
2017
Q3 		$10.4M Buy
127,607
+2,864
+2% +$227K 0.74% 28
2017
Q2 		$10M Sell
124,743
-5
-0% -$395 0.75% 28
2017
Q1 		$9.79M Buy
124,748
+11,558
+10% +$923K 0.74% 26
2016
Q4 		$8.93M Buy
113,190
+16,106
+17% +$1.3M 0.71% 30
2016
Q3 		$8.64M Sell
97,084
-1,611
-2% -$152K 0.74% 29
2016
Q2 		$9.45M Buy
98,695
+4,685
+5% +$467K 0.83% 26
2016
Q1 		$9.75M Buy
94,010
+6,919
+8% +$673K 0.91% 24
2015
Q4 		$8.52M Buy
87,091
+10,844
+14% +$1.06M 0.79% 28
2015
Q3 		$7.36M Buy
76,247
+755
+1% +$79.4K 0.83% 26
2015
Q2 		$7.92M Sell
75,492
-1,126
-1% -$115K 0.84% 27
2015
Q1 		$7.91M Sell
76,618
-4,654
-6% -$471K 0.85% 25
2014
Q4 		$7.83M Sell
81,272
-157
-0.2% -$13.8K 0.84% 26
2014
Q3 		$6.48M Sell
81,429
-1,470
-2% -$116K 0.74% 31
2014
Q2 		$6.25M Buy
82,899
+2,547
+3% +$192K 0.72% 33
2014
Q1 		$6.01M Buy
80,352
+5,951
+8% +$420K 0.74% 31
2013
Q4 		$5.33M Buy
74,401
+10,246
+16% +$658K 0.7% 33
2013
Q3 		$3.64M Buy
64,155
+654
+1% +$39K 0.56% 37
2013
Q2 		$3.63M Buy
+63,501
New +$3.68M 0.59% 35

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Raymond James Trust's CVS Position: Q3 2024 in Review

Raymond James Trust reduced its CVS Health (CVS) stake by 3.2% in Q3 2024, selling an estimated $543K and leaving 279,293 shares worth $17.6M. The position accounts for 0.38% of the portfolio, ranked #59.

Raymond James Trust first reported a position in CVS in Q2 2013 and has held it in 46 quarters since. The position peaked at $36.4M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Raymond James Trust held 279,293 shares of CVS Health worth $17.6M as of Q3 2024.
  • Raymond James Trust sold 9,310 CVS Health shares in Q3 2024, an estimated $543K.
  • CVS Health made up 0.38% of Raymond James Trust's portfolio in Q3 2024, its #59 holding.
  • Raymond James Trust first reported a position in CVS Health in Q2 2013 and has held it in 46 quarters since.
  • Raymond James Trust's CVS Health position peaked at $36.4M in Q4 2021.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.